Hype or hope? Ketamine for the treatment of depression: results from the application of deep learning to Twitter posts from 2010 to 2023
Frontiers in Psychiatry May 10, 2024 Qin Xiang Ng, Yu Liang Lim, Clarence Ong et al. 3 citations
Public attitudes toward ketamine for depression shifted notably after the U.S. Food and Drug Administration's 2019 approval. Analyzing 18,899 unique tweets from individual users between 2010 and 2023 revealed three main themes: changing regulations, cautious optimism, and personal experiences. Cautious optimism decreased over time, while personal accounts increasingly highlighted benefits for some treatment-resistant patients. The overall perception is hopeful about ketamine's therapeutic potential.